This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy Policy.

d4_bannerpc.jpg d4_bannerph.jpg

Novel Drug Delivery Systems

  • /Public/Uploads/uploadfile/images/20260415/d4img0101ph.jpg d4_img01_01.jpg

    Building on that foundation, Kingfriend masters novel drug delivery systems – nano fat emulsions (commercial‑scale, BE‑ready), liposomes (unilamellar and multivesicular), USFDA‑approved inclusion complexes, and nanoparticles. All under international cGMP, these technologies enhance bioavailability, reduce toxicity, and extend product lifecycle.


  • Building on that foundation, Kingfriend masters novel drug delivery systems – nano fat emulsions (commercial‑scale, BE‑ready), liposomes (unilamellar and multivesicular), USFDA‑approved inclusion complexes, and nanoparticles. All under international cGMP, these technologies enhance bioavailability, reduce toxicity, and extend product lifecycle.


d4_img02.jpg

Biologics Platform

At the cutting edge, Kingfriend’s biologics and next‑generation modalities platform covers mammalian and insect cell expression, mRNA with LNP delivery, ADCs, and high‑concentration antibody formulations. Integrated with OEB 5 isolation and automated lines, we maximize purification yield and support innovative therapies from concept to patient.